Active Ingredient(s): Sevelamer Carbonate
FDA Approved: * October 19, 2007
Pharm Company: * GENZYME
Category: Hyperphosphatemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Renvela Overview

Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Contents 1 Chemistry and pharmacology 2 Medical uses 3 Contraindications 4 Adverse effects 5 Other eff...

Read more Renvela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Renvela Forums: RSS Feed

renal softgel

this medicine is a black oval-shaped capsule imprinted with C162. Add info: white inksoft-gel. I want to know what all is in this vitamin and the strengths ## I have dialisis (3 times for week) and I take Renvela is neccesary me take Renal gel caps because before take and now no take and my phosforu is high,Pkease I'wait for you answer,I'm sorry for my English Ispeak Spanish Tanks you ## To answer the question of the original poster, each Renal cap softgel (imprint: C 162) contains the following ingredients: Vitamin C (ascorbic acid)........................100 mg Thiamine (as thiamine mononitrate)..........1.5 mg Riboflavin...............................................1.7 mg Niacin (as niacinamide).............................20 mg Vitamin B6 (as pyridoxine HCl)...................


Possible Dosages for this and Related Drugs:

Sevelamer Carbonate
  • Capsule: 400mg, 403mg
  • For Suspension: 2.4gm/packet, 800mg/packet
  • Tablet: 400mg, 800mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Renvela: (8 results)

Sorted by National Drug Code
  • 0179-0043 Renvela 800 mg Oral Tablet by Kaiser Foundation Hospitals
  • 17856-0130 Renvela 800 mg Oral Tablet, Film Coated by Atlantic Biologicals Corps
  • 55154-9728 Renvela 800 mg Oral Tablet by Cardinal Health
  • 58468-0130 Renvela 800 mg Oral Tablet by Genzyme Corporation
  • 58468-0131 Renvela 2400 mg/1 Oral Powder, for Suspension by Genzyme Corporation
  • 58468-0132 Renvela 800 mg/1 Oral Powder, for Suspension by Genzyme Corporation
  • 68151-5113 Renvela 800 mg Oral Tablet, Film Coated by Carilion Materials Management
  • 69189-0133 Renvela 800 mg Oral Tablet, Film Coated by Avera Mckennan Hospital

Other drugs which contain Sevelamer Carbonate or a similar ingredient: (2 results)

Related Renvela Topics:

Do you take renvela before, during or after eating?...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA